See more : 4D Molecular Therapeutics, Inc. (FDMT) Income Statement Analysis – Financial Results
Complete financial analysis of Helvetia Holding AG (HLVTY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Helvetia Holding AG, a leading company in the Insurance – Diversified industry within the Financial Services sector.
- Pasupati Acrylon Limited (PASUPTAC.NS) Income Statement Analysis – Financial Results
- Theon International PLC (W8C.SG) Income Statement Analysis – Financial Results
- National Beverage Corp. (0K50.L) Income Statement Analysis – Financial Results
- AirAsia X Berhad (5238.KL) Income Statement Analysis – Financial Results
- Olympia Industries Limited (OLYMPTX.BO) Income Statement Analysis – Financial Results
Helvetia Holding AG (HLVTY)
About Helvetia Holding AG
Helvetia Holding AG, through its subsidiaries, engages in life and non-life insurance, and reinsurance business in Switzerland, Germany, Austria, Spain, Italy, France, Liechtenstein, and internationally. It offers life insurance products in the areas of investment-linked, group life, and others; non-life insurance products in the areas of property, motor vehicle, health/accident, liability, and transport; and annuity insurance products and pension plans. The company was founded in 1858 and is headquartered in Sankt Gallen, Switzerland.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 10.97B | 8.69B | 13.46B | 11.11B | 10.79B |
| Cost of Revenue | -672.25M | 0.59 | 0.05 | 0.64 | 0.42 |
| Gross Profit | 11.64B | 8.69B | 13.46B | 11.11B | 10.79B |
| Gross Profit Ratio | 106.13% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.11B | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 9.27B | -975.33M | -3.22B | -2.62B | -1.98B |
| Operating Expenses | 10.38B | 975.33M | 3.22B | 2.62B | 1.98B |
| Cost & Expenses | 10.38B | -8.41B | -12.86B | -10.49B | -10.08B |
| Interest Income | 15.98M | 8.30M | 13.82M | 5.03M | 729.47K |
| Interest Expense | 157.68M | 15.71M | 161.22M | 81.93M | 117.33M |
| Depreciation & Amortization | 162.58M | 157.58M | 203.33M | 124.44M | 68.12M |
| EBITDA | 727.53M | 754.61M | 1.10B | 546.98M | 749.36M |
| EBITDA Ratio | 6.63% | 7.04% | 5.77% | 6.35% | 7.09% |
| Operating Income | 588.89M | 450.34M | 573.14M | 581.76M | 696.73M |
| Operating Income Ratio | 5.37% | 5.18% | 4.26% | 5.23% | 6.46% |
| Total Other Income/Expenses | -181.61M | -15.88M | 158.37M | -241.15M | -40.47M |
| Income Before Tax | 407.28M | 583.63M | 731.52M | 340.61M | 563.91M |
| Income Before Tax Ratio | 3.71% | 6.72% | 5.43% | 3.06% | 5.23% |
| Income Tax Expense | 67.70M | 86.28M | 170.74M | 40.70M | 26.87M |
| Net Income | 307.93M | 459.45M | 531.30M | 275.32M | 537.81M |
| Net Income Ratio | 2.81% | 5.29% | 3.95% | 2.48% | 4.99% |
| EPS | 6.09 | 8.69 | 10.05 | 5.38 | 10.87 |
| EPS Diluted | 6.23 | 8.68 | 10.05 | 5.38 | 10.87 |
| Weighted Avg Shares Out | 54.06M | 52.90M | 52.86M | 51.21M | 49.47M |
| Weighted Avg Shares Out (Dil) | 52.83M | 52.90M | 52.84M | 51.18M | 49.46M |
Source: https://incomestatements.info
Category: Stock Reports